US FDA To Explore New Regulatory Pathways For Some Cellular Products
CBER DIRECTOR PETER MARKS SAYS FDA PLANS TO EXPLORE WHETHER THERE IS AN INTERMEDIATE PATHWAY BETWEEN TISSUE REGULATIONS AND A FULL BLA FOR CERTAIN CELLULAR PRODUCTS. Source: Nielsen Hobbs; the […]